Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Bluejay Diagnostics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +9 vs. Q2 2024
- Shares held
- 1.02M
- +912.8K (+883.2%) vs. Q2 2024
- Total value
- $129.0K
- +$56.7K (+78.3%) vs. Q2 2024
- New holders
- 11
- 2 more added
- Sold out
- 2
- 0 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BJDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $259.3K |
| Q1 2026 | 6 | $108.2K |
| Q4 2025 | 9 | $112.3K |
| Q3 2025 | 4 | $142.7K |
| Q2 2025 | 5 | $170.3K |
| Q1 2025 | 4 | $9.61K |
| Q4 2024 | 3 | $12.2K |
| Q3 2024 | 13 | $129.0K |
| Q2 2024 | 5 | $118.6K |
| Q1 2024 | 9 | $344.7K |
| Q4 2023 | 7 | $243.4K |
| Q3 2023 | 6 | $99.8K |
| Q2 2023 | 11 | $47.4K |
| Q1 2023 | 10 | $55.7K |
| Q4 2022 | 14 | $109.0K |
| Q3 2022 | 12 | $146.0K |
| Q2 2022 | 12 | $258.0K |
| Q1 2022 | 8 | $98.0K |
| Q4 2021 | 9 | $267.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Bluejay Diagnostics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Anson Funds Management LP | 319,280 | $40.5K | 0.01% | +249,770+359.3% | Added |
| Sabby Management, LLC | 305,224 | $38.8K | 0.54% | +305,224 | New |
| Renaissance Technologies LLC | 137,000 | $17.4K | 0.00% | +137,000 | New |
| UBS Group AG | 61,448 | $7.80K | 0.00% | +61,448 | New |
| Two Sigma Securities, LLC | 52,637 | $6.68K | 0.00% | +52,637 | New |
| Citadel Advisors LLC | 52,176 | $6.63K | 0.00% | +52,176 | New |
| HRT Financial LP | 39,644 | $5.00K | 0.00% | +39,644 | New |
| Geode Capital Management, LLC | 20,185 | $2.56K | 0.00% | +20,185 | New |
| Two Sigma Investments, LP | 11,004 | $1.40K | 0.00% | +11,004 | New |
| Jump Financial, LLC | 10,381 | $1.32K | 0.00% | +10,381 | New |
| Tower Research Capital LLC (TRC) | 7,145 | $907 | 0.00% | +2,843+66.1% | Added |
| Bank of America Corp | 51 | $6 | 0.00% | +51 | New |
| Advisor Group Holdings, Inc. | 3 | $0 | 0.00% | +3 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,047−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| CVI Holdings, LLC | – | – | – | – | Not filed |